Whether peptide-induced improvements in allergic disease persist after discontinuation, and for how long, is an open question for most peptides (except allergen-derived peptide immunotherapy, which does have multi-year follow-up data)
They also were 32% less likely to die from any cause, and 10% less likely to be hospitalized
Central MC4R activation induces erection in published male cohorts the mechanism behind PT-141 (bremelanotide), which is a selective MT-2-derived fragment
The executives responding most effectively to GLP-1 disruption are conversant with health science at a meaningful level, not in terms of marketing claims but in terms of understanding what happens to appetite, satiety, and food preference over a GLP-1 treatment period, what the data says about consumption patterns after discontinuation, and how those patterns affect demand planning across a portfolio
Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A